1. Ferlay, J, Colombet, M, Soerjomataram, I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941-1953.
Google Scholar | Crossref | Medline2. Forouzanfar, MH, Foreman, KJ, Delossantos, AM, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378:1461-1484.
Google Scholar | Crossref | Medline | ISI3. Kau, Y-C, Liu, F-C, Kuo, C-F, et al. Trend and survival outcome in Taiwan cervical cancer patients: a population-based study. Medicine. 2019;98:e14848.
Google Scholar | Crossref | Medline4. Chen, YY, You, SL, Chen, CA, et al. Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences. Br J Cancer. 2009;101:174-177.
Google Scholar | Crossref | Medline5. Shyu, IL, Hu, L-Y, Chen, Y-J, Wang, PH, Huang, BS. Risk factors for developing depression in women with cervical cancer: a nationwide population-based study in Taiwan. Int J Womens Health. 2019;11:135-141.
Google Scholar | Crossref | Medline6. Health Promotion Administration Ministry of Health and Welfare . Cancer Registry annual report, 2016 Taiwan; 2018:70.
Google Scholar7. Koh, W-J, Abu-Rustum, NR, Bean, S, et al. Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17:64-84.
Google Scholar | Crossref | Medline8. Quinn, MA, Benedet, JL, Odicino, F, et al. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95:S43-S103.
Google Scholar9. Howlader, N, Noone, AM, Krapcho, M, et al. SEER cancer statistics review, 1975-2016. National Cancer Institute. Accessed February 5, 2019. https://seer.cancer.gov/csr/1975_2016
Google Scholar10. Ginsburg, O, Bray, F, Coleman, MP, et al. The global burden of women’s cancers: a grand challenge in global health. Lancet. 2017;389:847-860.
Google Scholar | Crossref | Medline11. Tsai, L-Y, Lee, S-C, Wang, K-L, Tsay, SL, Tsai, JM. A correlation study of fear of cancer recurrence, illness representation, self-regulation, and quality of life among gynecologic cancer survivors in Taiwan. Taiwan J Obstet Gynecol. 2018;57:846-852.
Google Scholar | Crossref | Medline12. Huang, H-Y, Tsai, W-C, Chou, W-Y, et al. Quality of life of breast and cervical cancer survivors. BMC Womens Health. 2017;17:30.
Google Scholar | Crossref | Medline13. Qi, F, Li, A, Inagaki, Y, et al. Chinese herbal medicines as adjuvant treatment during chemoor radio-therapy for cancer. Biosci Trends. 2010;4:297-307.
Google Scholar | Medline | ISI14. Qi, F, Zhao, L, Zhou, A, et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends. 2015;9:16-34.
Google Scholar | Crossref | Medline | ISI15. Fleischer, T, Chang, TT, Chiang, JH, Yen, HR. A controlled trial of Sheng-Yu-Tang for post-hematopoietic stem cell transplantation leukemia patients: a proposed protocol and insights from a preliminary pilot study. Integr Cancer Ther. 2018;17:665-673. doi:10.1177/1534735418756736
Google Scholar | SAGE Journals | ISI16. Song, YC, Huang, HC, Chang, CY, et al. A potential herbal adjuvant combined with a peptide-based vaccine acts against HPV-Related tumors through enhancing effector and memory T-cell immune responses. Front Immunol. 2020;11:62. doi:10.3389/fimmu.2020.00062
Google Scholar | Crossref | Medline17. Song, YC, Hung, KF, Liang, KL, et al. Adjunctive Chinese herbal medicine therapy for nasopharyngeal carcinoma: clinical evidence and experimental validation. Head Neck. 2019;41:2860-2872. doi:10.1002/hed.25766
Google Scholar | Crossref | Medline18. Fleischer, T, Chang, TT, Chiang, JH, Sun, MF, Yen, HR. Improved survival with integration of Chinese herbal medicine therapy in patients with acute myeloid leukemia: a nationwide population-based cohort study. Integr Cancer Ther. 2017;16:156-164. doi:10.1177/1534735416664171
Google Scholar | SAGE Journals | ISI19. Huang, CY, Wu, MY, Kuo, YH, Tou, SI, Yen, HR. Chinese herbal medicine Is helpful for survival improvement in patients with multiple myeloma in Taiwan: a nationwide retrospective matched-cohort study. Integr Cancer Ther. 2020;19:1534735420943280. doi:10.1177/1534735420943280
Google Scholar | SAGE Journals | ISI20. Hung, KF, Hsu, CP, Chiang, JH, et al. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: a nationwide retrospective matched-cohort study. J Ethnopharmacol. 2017;199:168-174. doi:10.1016/j.jep.2017.02.004
Google Scholar | Crossref | Medline21. Kuo, YT, Chang, TT, Muo, CH, et al. Use of complementary traditional Chinese medicines by adult cancer patients in Taiwan: a nationwide population-based study. Integr Cancer Ther. 2018;17:531-541. doi:10.1177/1534735417716302
Google Scholar | SAGE Journals | ISI22. Kuo, YT, Liao, HH, Chiang, JH, et al. Complementary Chinese herbal medicine therapy improves survival of patients with pancreatic cancer in Taiwan: a nationwide population-based cohort study. Integr Cancer Ther. 2018;17:411-422. doi:10.1177/1534735417722224
Google Scholar | SAGE Journals | ISI23. Chung, VC, Wu, X, Hui, EP, et al. Effectiveness of Chinese herbal medicine for cancer palliative care: overview of systematic reviews with meta-analyses. Sci Rep. 2015;5:18111.
Google Scholar | Crossref | Medline24. National Health Insurance Administration Ministry of Health and Welfare . National Health Insurance Annual Report 2014–2015. Ministry of Health and Welfare Taipei; 2014.
Google Scholar25. Ding, W, Ji, T, Xiong, W, Li, T, Pu, D, Liu, R. Realgar, a traditional Chinese medicine, induces apoptosis of hPV16-positive cervical cells through a hPV16 e7-related pathway. Drug Des Dev Ther. 2018;12:3459-3469.
Google Scholar | Crossref | Medline26. Zuo, HJ, Liu, S, Yan, C, Li, LM, Pei, XF. In vitro and in vivo evaluation of antitumor activity of Ligustrum robustum, a Chinese herbal tea. Chin J Integr Med. 2019;25:425-430.
Google Scholar | Crossref | Medline27. Zhang, M, Yu, Y, Zhang, H, et al. Synergistic cytotoxic effects of a combined treatment of a Pinellia pedatisecta lipid-soluble extract and cisplatin on human cervical carcinoma in vivo. Oncol Lett. 2017;13:4748-4754.
Google Scholar | Crossref | Medline28. Li, M, Hu, S, Chen, X, Wang, R, Bai, X. Research on major antitumor active components in Zi-Cao-Cheng-Qi decoction based on hollow fiber cell fishing with high performance liquid chromatography. J Pharm Biomed Anal. 2018;149:9-15.
Google Scholar | Crossref | Medline29. Adams, C, Grey, N, Magrath, I, Miller, A, Torode, J. The World Cancer Declaration: is the world catching up? Lancet Oncol. 2010;11:1018-1020.
Google Scholar | Crossref | Medline30. Bray, F, Jemal, A, Grey, N, Ferlay, J, Forman, D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol. 2012;13:790-801.
Google Scholar | Crossref | Medline | ISI31. Ferris, FD, Bruera, E, Cherny, N, et al. Palliative cancer care a decade later: accomplishments, the need, next steps—from the American Society of Clinical Oncology. J Clin Oncol. 2009;27:3052-3058.
Google Scholar | Crossref | Medline | ISI32. Landoni, F, Maneo, A, Colombo, A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350:535-540.
Google Scholar | Crossref | Medline | ISI33. Peters, WA, Liu, PY, Barrett, RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Obstet Gynecol Surv. 2000;55:491-492.
Google Scholar | Crossref34. Moore, DH, Blessing, JA, McQuellon, RP, et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol. 2004;22:3113-3119.
Google Scholar | Crossref | Medline | ISI35. Niu, Y, Meng, Q-X. Chemical and preclinical studies on Hedyotis diffusa with anticancer potential. J Asian Nat Prod Res. 2013;15:550-565.
Google Scholar | Crossref | Medline | ISI36. Liu, X, Wu, J, Zhang, D, Wang, K, Duan, X, Zhang, X. A network pharmacology approach to uncover the multiple mechanisms of Hedyotis diffusa Willd. on colorectal cancer. Evid Based Complement Alternat Med. 2018;2018:1-12.
Google Scholar37. Sun, G, Wei, L, Feng, J, Lin, J, Peng, J. Inhibitory effects of Hedyotis diffusa Willd. on colorectal cancer stem cells. Oncol Lett. 2016;11:3875-3881.
Google Scholar | Crossref | Medline38. Lin, J, Li, Q, Chen, H, Lin, H, Lai, Z, Peng, J. Hedyotis diffusa Willd. extract suppresses proliferation and induces apoptosis via IL-6-inducible STAT3 pathway inactivation in human colorectal cancer cells. Oncol Lett. 2015;9:1962-1970.
Google Scholar | Crossref | Medline39. Li, YL, Zhang, J, Min, D, Hongyan, Z, Lin, N, Li, QS. Anticancer effects of 1,3-dihydroxy-2-methylanthraquinone and the ethyl acetate fraction of Hedyotis diffusa Willd against HepG2 carcinoma cells mediated via apoptosis. PLoS One. 2016;11:e0151502.
Google Scholar40. Su, X, Li, Y, Jiang, M, et al. Systems pharmacology uncover the mechanism of anti-non-small cell lung cancer for Hedyotis diffusa Willd. Biomed Pharmacother. 2019;109:969-984.
Google Scholar | Crossref | Medline41. Hu, E, Wang, D, Chen, J, Tao, X. Novel cyclotides from Hedyotis diffusa induce apoptosis and inhibit proliferation and migration of prostate cancer cells. Int J Clin Exp Med. 2015;8:4059-4065.
Google Scholar | Medline | ISI42. Lin, J, Chen, Y, Wei, L, et al. Hedyotis diffusa Willd extract induces apoptosis via activation of the mitochondrion-dependent pathway in human colon carcinoma cells. Internet J Oncol. 2010;37:1331-1338.
Google Scholar | Medline | ISI43. Zhang, L, Ren, B, Zhang, J, et al. Anti-tumor effect of Scutellaria barbata D. Don extracts on ovarian cancer and its phytochemicals characterisation. J Ethnopharmacol. 2017;206:184-192.
Google Scholar | Crossref | Medline44. Sun, P, Sun, D, Wang, X. Effects of Scutellaria barbata polysaccharide on the proliferation, apoptosis and EMT of human colon cancer HT29 cells. Carbohydr Polym. 2017;167:90-96.
Google Scholar | Crossref | Medline45. Pan, L-T, Sheung, Y, Guo, W-P, Rong, ZB, Cai, ZM. Hedyotis diffusa plus Scutellaria barbata induce bladder cancer cell apoptosis by inhibiting Akt signaling pathway through downregulating miR-155 expression. Evid Based Complement Alternat Med. 2016;2016:1-10.
Google Scholar46. Wang, M, Chen, Y, Hu, P, Ji, J, Li, X, Chen, J. Neoclerodane diterpenoids from Scutellaria barbata with cytotoxic activities. Nat Prod Res. 2020;34:1345-1351.
Google Scholar | Crossref | Medline47. Nie, X-P, Qu, GW, Yue, X-D, Li, GS, Dai, SJ. Scutelinquanines A–C, three new cytotoxic neo-clerodane diterpenoid from Scutellaria barbata. Phytochem Lett. 2010;3:190-193.
Google Scholar | Crossref48. Perez, AT, Arun, B, Tripathy, D, et al. A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat. 2010;120:111-118.
Google Scholar | Crossref | Medline49. Cheng, Y-Y, Hsieh, C-H, Tsai, T-H. Concurrent administration of anticancer chemotherapy drug and herbal medicine on the perspective of pharmacokinetics. J Food Drug Anal. 2018;26:S88-S95.
Google Scholar | Crossref